Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study

Susan P. Etheridge, Carolina A. Escudero, Andrew D. Blaufox, Ian H. Law, Brynn E. Dechert-Crooks, Elizabeth A. Stephenson, Anne M. Dubin, Scott R. Ceresnak, Kara S. Motonaga, Jonathan R. Skinner, Luciana D. Marcondes, James C. Perry, Kathryn K. Collins, Stephen P. Seslar, Michel Cabrera, Orhan Uzun, Bryan C. Cannon, Peter F. Aziz, Peter Kubuš, Ronn E. TanelSantiago O. Valdes, Sara Sami, Naomi J. Kertesz, Jennifer Maldonado, Christopher Erickson, Jeremy P. Moore, Hiroko Asakai, Lu Ann Mill, Mark Abcede, Zebulon Z. Spector, Shaji Menon, Mark Shwayder, David J. Bradley, Mitchell I. Cohen, Shubhayan Sanatani

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objectives: This study sought to characterize risk in children with Wolff-Parkinson-White (WPW) syndrome by comparing those who had experienced a life-threatening event (LTE) with a control population. Background: Children with WPW syndrome are at risk of sudden death. Methods: This retrospective multicenter pediatric study identified 912 subjects ≤21 years of age with WPW syndrome, using electrophysiology (EPS) studies. Case subjects had a history of LTE: sudden death, aborted sudden death, or atrial fibrillation (shortest pre-excited RR interval in atrial fibrillation [SPERRI] of ≤250 ms or with hemodynamic compromise); whereas subjects did not. We compared clinical and EPS data between cases and subjects. Results: Case subjects (n = 96) were older and less likely than subjects (n = 816) to have symptoms or documented tachycardia. Mean age at LTE was 14.1 ± 3.9 years of age. The LTE was the sentinel symptom in 65%, consisting of rapidly conducted pre-excited atrial fibrillation (49%), aborted sudden death (45%), and sudden death (6%). Three risk components were considered at EPS: SPERRI, accessory pathway effective refractory period (APERP), and shortest paced cycle length with pre-excitation during atrial pacing (SPPCL), and all were shorter in cases than in control subjects. In multivariate analysis, risk factors for LTE included male sex, Ebstein malformation, rapid anterograde conduction (APERP, SPERRI, or SPPCL ≤250 ms), multiple pathways, and inducible atrial fibrillation. Of case subjects, 60 of 86 (69%) had ≥2 EPS risk stratification components performed; 22 of 60 (37%) did not have EPS-determined high-risk characteristics, and 15 of 60 (25%) had neither concerning pathway characteristics nor inducible atrioventricular reciprocating tachycardia. Conclusions: Young patients may experience LTE from WPW syndrome without prior symptoms or markers of high-risk on EPS.

Original languageEnglish (US)
Pages (from-to)433-444
Number of pages12
JournalJACC: Clinical Electrophysiology
Volume4
Issue number4
DOIs
StatePublished - Apr 2018

Fingerprint

Wolff-Parkinson-White Syndrome
Electrophysiology
Multicenter Studies
Sudden Death
Atrial Fibrillation
Reciprocating Tachycardia
Ebstein Anomaly
Life Change Events
Tachycardia
Multivariate Analysis
Hemodynamics
Pediatrics
Population

Keywords

  • Wolff-Parkinson-White syndrome
  • pediatrics
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Etheridge, S. P., Escudero, C. A., Blaufox, A. D., Law, I. H., Dechert-Crooks, B. E., Stephenson, E. A., ... Sanatani, S. (2018). Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study. JACC: Clinical Electrophysiology, 4(4), 433-444. https://doi.org/10.1016/j.jacep.2017.10.009

Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome : A Multicenter International Study. / Etheridge, Susan P.; Escudero, Carolina A.; Blaufox, Andrew D.; Law, Ian H.; Dechert-Crooks, Brynn E.; Stephenson, Elizabeth A.; Dubin, Anne M.; Ceresnak, Scott R.; Motonaga, Kara S.; Skinner, Jonathan R.; Marcondes, Luciana D.; Perry, James C.; Collins, Kathryn K.; Seslar, Stephen P.; Cabrera, Michel; Uzun, Orhan; Cannon, Bryan C.; Aziz, Peter F.; Kubuš, Peter; Tanel, Ronn E.; Valdes, Santiago O.; Sami, Sara; Kertesz, Naomi J.; Maldonado, Jennifer; Erickson, Christopher; Moore, Jeremy P.; Asakai, Hiroko; Mill, Lu Ann; Abcede, Mark; Spector, Zebulon Z.; Menon, Shaji; Shwayder, Mark; Bradley, David J.; Cohen, Mitchell I.; Sanatani, Shubhayan.

In: JACC: Clinical Electrophysiology, Vol. 4, No. 4, 04.2018, p. 433-444.

Research output: Contribution to journalArticle

Etheridge, SP, Escudero, CA, Blaufox, AD, Law, IH, Dechert-Crooks, BE, Stephenson, EA, Dubin, AM, Ceresnak, SR, Motonaga, KS, Skinner, JR, Marcondes, LD, Perry, JC, Collins, KK, Seslar, SP, Cabrera, M, Uzun, O, Cannon, BC, Aziz, PF, Kubuš, P, Tanel, RE, Valdes, SO, Sami, S, Kertesz, NJ, Maldonado, J, Erickson, C, Moore, JP, Asakai, H, Mill, LA, Abcede, M, Spector, ZZ, Menon, S, Shwayder, M, Bradley, DJ, Cohen, MI & Sanatani, S 2018, 'Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study', JACC: Clinical Electrophysiology, vol. 4, no. 4, pp. 433-444. https://doi.org/10.1016/j.jacep.2017.10.009
Etheridge, Susan P. ; Escudero, Carolina A. ; Blaufox, Andrew D. ; Law, Ian H. ; Dechert-Crooks, Brynn E. ; Stephenson, Elizabeth A. ; Dubin, Anne M. ; Ceresnak, Scott R. ; Motonaga, Kara S. ; Skinner, Jonathan R. ; Marcondes, Luciana D. ; Perry, James C. ; Collins, Kathryn K. ; Seslar, Stephen P. ; Cabrera, Michel ; Uzun, Orhan ; Cannon, Bryan C. ; Aziz, Peter F. ; Kubuš, Peter ; Tanel, Ronn E. ; Valdes, Santiago O. ; Sami, Sara ; Kertesz, Naomi J. ; Maldonado, Jennifer ; Erickson, Christopher ; Moore, Jeremy P. ; Asakai, Hiroko ; Mill, Lu Ann ; Abcede, Mark ; Spector, Zebulon Z. ; Menon, Shaji ; Shwayder, Mark ; Bradley, David J. ; Cohen, Mitchell I. ; Sanatani, Shubhayan. / Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome : A Multicenter International Study. In: JACC: Clinical Electrophysiology. 2018 ; Vol. 4, No. 4. pp. 433-444.
@article{e9cf8c231d974c95a95c82eb7e67e07f,
title = "Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study",
abstract = "Objectives: This study sought to characterize risk in children with Wolff-Parkinson-White (WPW) syndrome by comparing those who had experienced a life-threatening event (LTE) with a control population. Background: Children with WPW syndrome are at risk of sudden death. Methods: This retrospective multicenter pediatric study identified 912 subjects ≤21 years of age with WPW syndrome, using electrophysiology (EPS) studies. Case subjects had a history of LTE: sudden death, aborted sudden death, or atrial fibrillation (shortest pre-excited RR interval in atrial fibrillation [SPERRI] of ≤250 ms or with hemodynamic compromise); whereas subjects did not. We compared clinical and EPS data between cases and subjects. Results: Case subjects (n = 96) were older and less likely than subjects (n = 816) to have symptoms or documented tachycardia. Mean age at LTE was 14.1 ± 3.9 years of age. The LTE was the sentinel symptom in 65{\%}, consisting of rapidly conducted pre-excited atrial fibrillation (49{\%}), aborted sudden death (45{\%}), and sudden death (6{\%}). Three risk components were considered at EPS: SPERRI, accessory pathway effective refractory period (APERP), and shortest paced cycle length with pre-excitation during atrial pacing (SPPCL), and all were shorter in cases than in control subjects. In multivariate analysis, risk factors for LTE included male sex, Ebstein malformation, rapid anterograde conduction (APERP, SPERRI, or SPPCL ≤250 ms), multiple pathways, and inducible atrial fibrillation. Of case subjects, 60 of 86 (69{\%}) had ≥2 EPS risk stratification components performed; 22 of 60 (37{\%}) did not have EPS-determined high-risk characteristics, and 15 of 60 (25{\%}) had neither concerning pathway characteristics nor inducible atrioventricular reciprocating tachycardia. Conclusions: Young patients may experience LTE from WPW syndrome without prior symptoms or markers of high-risk on EPS.",
keywords = "Wolff-Parkinson-White syndrome, pediatrics, sudden death",
author = "Etheridge, {Susan P.} and Escudero, {Carolina A.} and Blaufox, {Andrew D.} and Law, {Ian H.} and Dechert-Crooks, {Brynn E.} and Stephenson, {Elizabeth A.} and Dubin, {Anne M.} and Ceresnak, {Scott R.} and Motonaga, {Kara S.} and Skinner, {Jonathan R.} and Marcondes, {Luciana D.} and Perry, {James C.} and Collins, {Kathryn K.} and Seslar, {Stephen P.} and Michel Cabrera and Orhan Uzun and Cannon, {Bryan C.} and Aziz, {Peter F.} and Peter Kubuš and Tanel, {Ronn E.} and Valdes, {Santiago O.} and Sara Sami and Kertesz, {Naomi J.} and Jennifer Maldonado and Christopher Erickson and Moore, {Jeremy P.} and Hiroko Asakai and Mill, {Lu Ann} and Mark Abcede and Spector, {Zebulon Z.} and Shaji Menon and Mark Shwayder and Bradley, {David J.} and Cohen, {Mitchell I.} and Shubhayan Sanatani",
year = "2018",
month = "4",
doi = "10.1016/j.jacep.2017.10.009",
language = "English (US)",
volume = "4",
pages = "433--444",
journal = "JACC: Clinical Electrophysiology",
issn = "2405-5018",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome

T2 - A Multicenter International Study

AU - Etheridge, Susan P.

AU - Escudero, Carolina A.

AU - Blaufox, Andrew D.

AU - Law, Ian H.

AU - Dechert-Crooks, Brynn E.

AU - Stephenson, Elizabeth A.

AU - Dubin, Anne M.

AU - Ceresnak, Scott R.

AU - Motonaga, Kara S.

AU - Skinner, Jonathan R.

AU - Marcondes, Luciana D.

AU - Perry, James C.

AU - Collins, Kathryn K.

AU - Seslar, Stephen P.

AU - Cabrera, Michel

AU - Uzun, Orhan

AU - Cannon, Bryan C.

AU - Aziz, Peter F.

AU - Kubuš, Peter

AU - Tanel, Ronn E.

AU - Valdes, Santiago O.

AU - Sami, Sara

AU - Kertesz, Naomi J.

AU - Maldonado, Jennifer

AU - Erickson, Christopher

AU - Moore, Jeremy P.

AU - Asakai, Hiroko

AU - Mill, Lu Ann

AU - Abcede, Mark

AU - Spector, Zebulon Z.

AU - Menon, Shaji

AU - Shwayder, Mark

AU - Bradley, David J.

AU - Cohen, Mitchell I.

AU - Sanatani, Shubhayan

PY - 2018/4

Y1 - 2018/4

N2 - Objectives: This study sought to characterize risk in children with Wolff-Parkinson-White (WPW) syndrome by comparing those who had experienced a life-threatening event (LTE) with a control population. Background: Children with WPW syndrome are at risk of sudden death. Methods: This retrospective multicenter pediatric study identified 912 subjects ≤21 years of age with WPW syndrome, using electrophysiology (EPS) studies. Case subjects had a history of LTE: sudden death, aborted sudden death, or atrial fibrillation (shortest pre-excited RR interval in atrial fibrillation [SPERRI] of ≤250 ms or with hemodynamic compromise); whereas subjects did not. We compared clinical and EPS data between cases and subjects. Results: Case subjects (n = 96) were older and less likely than subjects (n = 816) to have symptoms or documented tachycardia. Mean age at LTE was 14.1 ± 3.9 years of age. The LTE was the sentinel symptom in 65%, consisting of rapidly conducted pre-excited atrial fibrillation (49%), aborted sudden death (45%), and sudden death (6%). Three risk components were considered at EPS: SPERRI, accessory pathway effective refractory period (APERP), and shortest paced cycle length with pre-excitation during atrial pacing (SPPCL), and all were shorter in cases than in control subjects. In multivariate analysis, risk factors for LTE included male sex, Ebstein malformation, rapid anterograde conduction (APERP, SPERRI, or SPPCL ≤250 ms), multiple pathways, and inducible atrial fibrillation. Of case subjects, 60 of 86 (69%) had ≥2 EPS risk stratification components performed; 22 of 60 (37%) did not have EPS-determined high-risk characteristics, and 15 of 60 (25%) had neither concerning pathway characteristics nor inducible atrioventricular reciprocating tachycardia. Conclusions: Young patients may experience LTE from WPW syndrome without prior symptoms or markers of high-risk on EPS.

AB - Objectives: This study sought to characterize risk in children with Wolff-Parkinson-White (WPW) syndrome by comparing those who had experienced a life-threatening event (LTE) with a control population. Background: Children with WPW syndrome are at risk of sudden death. Methods: This retrospective multicenter pediatric study identified 912 subjects ≤21 years of age with WPW syndrome, using electrophysiology (EPS) studies. Case subjects had a history of LTE: sudden death, aborted sudden death, or atrial fibrillation (shortest pre-excited RR interval in atrial fibrillation [SPERRI] of ≤250 ms or with hemodynamic compromise); whereas subjects did not. We compared clinical and EPS data between cases and subjects. Results: Case subjects (n = 96) were older and less likely than subjects (n = 816) to have symptoms or documented tachycardia. Mean age at LTE was 14.1 ± 3.9 years of age. The LTE was the sentinel symptom in 65%, consisting of rapidly conducted pre-excited atrial fibrillation (49%), aborted sudden death (45%), and sudden death (6%). Three risk components were considered at EPS: SPERRI, accessory pathway effective refractory period (APERP), and shortest paced cycle length with pre-excitation during atrial pacing (SPPCL), and all were shorter in cases than in control subjects. In multivariate analysis, risk factors for LTE included male sex, Ebstein malformation, rapid anterograde conduction (APERP, SPERRI, or SPPCL ≤250 ms), multiple pathways, and inducible atrial fibrillation. Of case subjects, 60 of 86 (69%) had ≥2 EPS risk stratification components performed; 22 of 60 (37%) did not have EPS-determined high-risk characteristics, and 15 of 60 (25%) had neither concerning pathway characteristics nor inducible atrioventricular reciprocating tachycardia. Conclusions: Young patients may experience LTE from WPW syndrome without prior symptoms or markers of high-risk on EPS.

KW - Wolff-Parkinson-White syndrome

KW - pediatrics

KW - sudden death

UR - http://www.scopus.com/inward/record.url?scp=85034441724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034441724&partnerID=8YFLogxK

U2 - 10.1016/j.jacep.2017.10.009

DO - 10.1016/j.jacep.2017.10.009

M3 - Article

C2 - 30067481

AN - SCOPUS:85034441724

VL - 4

SP - 433

EP - 444

JO - JACC: Clinical Electrophysiology

JF - JACC: Clinical Electrophysiology

SN - 2405-5018

IS - 4

ER -